Huilgol Shyamala C, Selva Dinesh, Chen Celia, Hill Dudley C, James Craig L, Gramp Amanda, Malhotra Raman
Department of Dermatology and Oculoplastic and Orbital Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia.
Arch Dermatol. 2004 Sep;140(9):1087-92. doi: 10.1001/archderm.140.9.1087.
To assess the margins required for excision of lentigo maligna (LM) and lentigo maligna melanoma (LMM) by the technique of mapped serial excision (MSE), and to assess the efficacy of MSE.
An interventional, prospective, noncontrolled case series.
Tertiary referral, dermatologic surgery unit.
Consecutive patients with head and neck LM or LMM who underwent MSE between March 1, 1993, and October 31, 2002.
The MSE of LM or LMM.
The number of 5-mm levels for excision of LM and LMM and recurrence.
One hundred sixty-one LMs or LMMs in 155 patients were treated. Thirty percent (37 of 125) of LMs required more than 5-mm margins. For LMMs less than 1 mm in Breslow thickness, 12% (4/32) required more than 10-mm margins. For primary tumors, 20% of LMs (18 of 91) required more than 5-mm margins, while 10% of LMMs less than 1 mm in Breslow thickness (2 of 21) required more than a 10-mm margin. For recurrent tumors, 56% of LMs (19/34) required more than a 5-mm margin. Mean follow-up of 38 months (range, 5-100 months) showed 4 recurrences (2%) after MSE. The extrapolated recurrence at 5 years was 5.0%.
The current recommendations of 5-mm margins for LM and 10-mm margins for LMM less than 1 mm in Breslow thickness are often insufficient. Our results demonstrate the importance of margin-controlled excision, particularly in recurrent lesions. The use of MSE offers a high cure rate, in conjunction with tissue conservation.
通过连续标记切除技术(MSE)评估恶性雀斑(LM)和恶性雀斑样痣黑色素瘤(LMM)切除所需的切缘,并评估MSE的疗效。
一项干预性、前瞻性、非对照病例系列研究。
三级转诊皮肤科手术科室。
1993年3月1日至2002年10月31日期间接受MSE治疗的头颈部LM或LMM连续患者。
LM或LMM的MSE。
LM和LMM切除的5毫米层面数量及复发情况。
155例患者的161处LM或LMM接受了治疗。30%(125处中的37处)的LM需要超过5毫米的切缘。对于Breslow厚度小于1毫米的LMM,12%(32处中的4处)需要超过10毫米的切缘。对于原发性肿瘤,20%的LM(91处中的18处)需要超过5毫米的切缘,而对于Breslow厚度小于1毫米的LMM,10%(21处中的2处)需要超过10毫米的切缘。对于复发性肿瘤,56%的LM(34处中的19处)需要超过5毫米的切缘。平均随访38个月(范围5 - 100个月)显示MSE后有4例复发(2%)。5年外推复发率为5.0%。
目前对于LM切缘5毫米、Breslow厚度小于1毫米的LMM切缘10毫米的建议通常是不够的。我们的结果表明切缘控制切除的重要性,特别是在复发性病变中。MSE的应用结合了组织保留,提供了较高的治愈率。